[Successful hyposensitization treatment of a patient with schizoaffective psychosis and carbamazepine allergy].
For the prevention of relapse in a 25 year old man with schizoaffective psychosis, lithium was prescribed but had to be discontinued because the patient developed psoriasis. Carbamazepine was started but had to be discontinued as the patient developed a generalized substance-induced skin rush. A six-week desensitization procedure with increased oral doses, starting with 1 mg per day, allowed relapse prevention with carbamazepine on a usual dosage. To our knowledge, this is the first report of a successful desensitization of a psychiatric patient with carbamazepine allergy.
Hermle
L
L
Christophsbad, Fachklinik für Psychiatrie und Neurologie, Göppingen.
Spitzer
M
M
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000628:therapy*; D006801:Humans; D008297:Male; D012008:Recurrence
D002220:Carbamazepine
Erfolgreiche Hyposensibilisierungsbehandlung bei einem Patienten mit einer schizoaffektiven Psychose und Carbamazepinallergie.